Inspire Medical Systems Q3 2026 Earnings Date & Estimates

Inspire Medical Systems (NYSE:INSP) is a medical technology company focused on developing and commercializing treatments for obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is the Inspire therapy system, an implantable device designed for certain adults with moderate to severe OSA who are unable to use or obtain consistent benefits from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses an implantable pulse generator, a stimulation lead and a sensing lead. During sleep, the system detects the patient’s breathing pattern and delivers mild stimulation to the hypoglossal nerve, helping move the tongue and other airway tissues to keep the airway open. Patients control the therapy with a handheld remote, and treatment is prescribed and managed through qualified physicians and sleep specialists.

Inspire Medical Systems was founded in 2007 and is headquartered in Golden Valley, Minnesota. Its therapy has received regulatory authorization in the United States and is available in selected international markets, including parts of Europe and other regions. The company markets its products through a network of healthcare providers and works with sleep centers, surgeons and other specialists involved in the diagnosis and treatment of sleep apnea.